EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Cause-specific mortality in treatment-resistant major depression: Population-based cohort study

Tapio T Gustafsson, Heidi Taipale, Markku Lähteenvuo, Antti Tanskanen, Tanja Svirskis, Saara Huoponen, Jari Tiihonen

Journal of Affective Disorders · 2025-01 · 368 · 136-142

DOI: 10.1016/j.jad.2024.09.064 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Affective Disorders, 2025-01. Verfasst von Tapio T Gustafsson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland. Electronic address: tapio.gustafsson@niuva.f…. Hauptthemen laut MEDLINE: Major Depressive Disorder, Depressive Disorder, Treatment-Resistant, Antidepressive Agents, Cause of Death. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Johnson & Johnson Innovative Medicine, Sosiaali- ja Terveysministeriö.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Limited evidence-base on long-term prognosis of treatment-resistant major depression (TRD) is a barrier to clinical decision-making. Therefore, the purpose of this study was to establish cause-specific mortality in TRD compared to non-TRD major depression. METHOD: We identified all individuals with a diagnosis of major depression (MDD) who were treated with an antidepressant aged 15 to 65 years during 2004-2016 in Finland. Persons with over two treatment trials were defined to have TRD. Data were analysed with Cox proportional hazard models. RESULTS: 176,942 individuals with MDD (63 % women, median age at index diagnosis 40 years), of whom 11 % (n = 19,305) fulfilled the TRD criteria, were followed-up for 1,525,646 person-years (median 8.9 years). There were 959 deaths (6.1 deaths/1000 person-years) in TRD and 7662 deaths (5.6/1000 person-years) in non-TRD. All-cause mortality was 17 % higher (adjusted hazard ratio (aHR), 1.17; 95 % confidence interval (CI), 1.09-1.25) in TRD compared to non-TRD, when sex and age at index antidepressant prescription were controlled for. In TRD, increased mortality was observed for suicides (aHR, 1.90; 95%CI, 1.64-2.20) and for accidental poisonings (aHR, 1.81; 95%CI, 1.48-2.22), but not for natural causes (aHR, 0.98; 95%CI, 0.90-1.07). A higher proportion of accidental drug overdoses was observed in TRD than in non-TRD (62 % vs 42 %, respectively). LIMITATIONS: Definition of TRD lacks consensus. We used routine data to define TRD. CONCLUSIONS: The markedly increased mortality due to suicides and accidental overdoses suggests that persons with TRD may experience higher intensity symptoms and more severe suicidal ideation than persons with non-TRD major depression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderDepressive Disorder, Treatment-ResistantAntidepressive AgentsCause of DeathHumansFemaleMaleAdultMiddle AgedFinlandAdolescentYoung AdultCohort StudiesAgedProportional Hazards ModelsSuicideDrug Overdose

Stichwörter der Autor:innen

DepressionMortalitySuicideTreatment-resistant

Substanzen

Antidepressive Agents

Autor:innen und Institutionen

  • Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland. Electronic address: tapio.gustafsson@niuva.fi.
  • Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; School of Pharmacy, University of E…
  • Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland.
  • Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Johnson & Johnson Innovative Medicine, P.O. Box 15 02621, Espoo, Finland.
  • Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Center for Psychiatry Research, Sto…

Förderung

  • Johnson & Johnson Innovative Medicine
  • Sosiaali- ja Terveysministeriö

Zitieren

APA

Gustafsson, T. T., Taipale, H., Lähteenvuo, M., Tanskanen, A., Svirskis, T., Huoponen, S., & Tiihonen, J. (2025). Cause-specific mortality in treatment-resistant major depression: Population-based cohort study. Journal of Affective Disorders, 368, 136-142. https://doi.org/10.1016/j.jad.2024.09.064

Vancouver

Gustafsson TT, Taipale H, Lähteenvuo M, Tanskanen A, Svirskis T, Huoponen S, et al. Cause-specific mortality in treatment-resistant major depression: Population-based cohort study. Journal of Affective Disorders. 2025;368:136-142. doi:10.1016/j.jad.2024.09.064

BibTeX
@article{Gustafsson2025,
  author = {Gustafsson, Tapio T and Taipale, Heidi and Lähteenvuo, Markku and Tanskanen, Antti and Svirskis, Tanja and Huoponen, Saara and Tiihonen, Jari},
  title = {Cause-specific mortality in treatment-resistant major depression: Population-based cohort study},
  journal = {Journal of Affective Disorders},
  year = {2025},
  volume = {368},
  pages = {136--142},
  doi = {10.1016/j.jad.2024.09.064}
}
Kostenlos starten →